By IntelliNews Ukraine’s economic debate is increasingly shifting from short-term wartime survival toward the question of how ...

Patients with left main coronary artery disease had similar 10-year mortality after PCI or CABG, according to new data. Read ...

Temferon demonstrated potential in glioblastoma treatment, with long-term survivors and improved survival rates compared to historical data. The therapy reprograms the tumor microenvironment, inducing ...

IntroductionBruton’s tyrosine kinase (BTK) is at the core of present day treatment in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) which in turn is redefining first line and ...

Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose. A higher dose of radiation ...

About 90% of patients with advanced melanoma who had a complete response to first-line immune checkpoint inhibitors survived more than 3 years, with survival curves plateauing over time, a large ...

An investigator reported 10-year follow-up data from a phase 3 trial of extended vs limited pelvic lymph node dissection during radical prostatectomy.

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

Surviving the illness does not mean people fully recover. Many patients continue to suffer long-term physical and mental health problems. View on euronews ...